Beth Israel

Keches Law Teams Up with Bosworth Law Filing Lawsuit Against Drug Manufacturer Bayer, Beth Israel Deaconess After UTI Antibiotic Leaves 44-Year-Old Walpole Woman Unable to Walk

Retrieved on: 
Thursday, May 2, 2024
UTI, Beth Israel, Blackbox, Talia, Superior, Docket, Lawsuit, Injury, Smith, Failure, Central nervous system, WFXT, Massachusetts General Hospital, Nursing

Smith alleges in the lawsuit that the Beth Israel Deaconess nurse practitioner who prescribed her Cipro for a minor UTI never explained any of the risks or side effects of Cipro.

Key Points: 
  • Smith alleges in the lawsuit that the Beth Israel Deaconess nurse practitioner who prescribed her Cipro for a minor UTI never explained any of the risks or side effects of Cipro.
  • As a result of her injuries, Smith has been hospitalized numerous times, even spending her 42nd birthday admitted to Massachusetts General Hospital.
  • Once a thriving employee climbing the ladder at her corporate job, Smith is now completely disabled and unable to work at all.
  • "No antibiotic that can permanently disable a healthy person should ever be prescribed in this country to treat a routine UTI," said Bosworth .

Basking Biosciences Presents Novel Reversible RNA-aptamer Thrombolytic at Locus Walk RNA Innovation Conference

Retrieved on: 
Tuesday, May 9, 2023
Science, Neurology, Biotechnology, Research, Pharmaceutical, General Health, Health, Clinical Trials, Partnership, University of Massachusetts, Bleeding, Stroke, Toxicity, Brain, RNA, Willebrand, Von Willebrand factor, Blood, MRI, Patient, Thrombus, Beth Israel, Aptamer, Conference, Vaccine

Basking Biosciences (Basking), a clinical-stage biopharmaceutical company, today discussed the development status of BB-031, the company’s novel, RNA-based thrombolytic for use in patients experiencing acute ischemic stroke, at the Locus Walk RNA Innovation Conference, held virtually.

Key Points: 
  • Basking Biosciences (Basking), a clinical-stage biopharmaceutical company, today discussed the development status of BB-031, the company’s novel, RNA-based thrombolytic for use in patients experiencing acute ischemic stroke, at the Locus Walk RNA Innovation Conference, held virtually.
  • BB-031, a rapid onset, short-acting agent, is an RNA aptamer targeting von Willebrand Factor (vWF), a key structural component of thrombi and driver of blood clotting.
  • Uniquely, the thrombolytic activity of BB-031 is designed to be quickly neutralized in the event of bleeding using a complementary agent, BB-025, which Basking is developing in tandem.
  • “RNA aptamers have a number of characteristics that make them exceptionally well suited for treating acute thrombosis,” said Richard Shea, Chief Executive Officer of Basking.

Kernal Biologics to Present at Locust Walk RNA Innovation Conference

Retrieved on: 
Tuesday, May 9, 2023
John Smol, RNA, Partnership, University of Massachusetts, RNA editing, Research, Beth Israel, Conference, Vaccine

CAMBRIDGE, Mass., May 9, 2023 /PRNewswire/ -- Kernal Bio, a venture-backed biotech company developing mRNA 2.0 immunotherapies, announced today that Yusuf Erkul, M.D., Co-founder & CEO, will present the company's novel mRNA 2.0 platform at the Locust Walk RNA Innovation Conference on Tuesday, May 9, 2023, at 1:00 p.m.

Key Points: 
  • CAMBRIDGE, Mass., May 9, 2023 /PRNewswire/ -- Kernal Bio, a venture-backed biotech company developing mRNA 2.0 immunotherapies, announced today that Yusuf Erkul, M.D., Co-founder & CEO, will present the company's novel mRNA 2.0 platform at the Locust Walk RNA Innovation Conference on Tuesday, May 9, 2023, at 1:00 p.m.
  • The Locust Walk RNA Innovation Conference is hosted in partnership with Dr. Frank Slack, Director of the Beth Israel RNA Medicine Initiative, and Dr. Phil Zamore, Director of the UMass Chan RNA Medicine Institute.
  • Locust Walk is hosting a virtual one-day investor and partner conference exploring innovations in RNA research and development, including: Protein expression, RNA editing, RNA-mediated protein & transcriptome regulation, RNA targeting SMOLs, translation inhibition and novel delivery approaches.
  • The event will showcase cutting-edge science, industry trends, and high-value opportunities in next-generation in RNA R&D.

Anima Biotech to Present at Locust Walk RNA Innovation Conference

Retrieved on: 
Monday, May 8, 2023
Partnership, MOA, University of Massachusetts, Research, RNA, Messenger, Science, Beth Israel, AI, Conference, Vaccine

BERNARDSVILLE, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven MOA elucidation, today announced that Iris Alroy, Ph.D., chief scientific officer and co-founder of Anima, will present the company's mRNA Lightning™ platform at the upcoming Locust Walk RNA Innovation Conference.

Key Points: 
  • BERNARDSVILLE, N.J., May 08, 2023 (GLOBE NEWSWIRE) -- Anima Biotech, the leader in the discovery of small molecule mRNA drugs and their mechanisms of action by phenotypic screening with AI driven MOA elucidation, today announced that Iris Alroy, Ph.D., chief scientific officer and co-founder of Anima, will present the company's mRNA Lightning™ platform at the upcoming Locust Walk RNA Innovation Conference.
  • ET and will highlight how Anima is advancing the science of mRNA regulation through its innovative approach.
  • The Locust Walk RNA Innovation Conference is hosted in partnership with Frank Slack, Ph.D., Director of the Beth Israel RNA Medicine Initiative, and Phil Zamore, Ph.D., Director of the UMass Chan RNA Medicine Institute.
  • Locust Walk is hosting a virtual one-day investor and partner conference exploring innovations in RNA research and development, including:

Headlands Research Acquires Established Eastern Massachusetts–Based Research Site Specializing in Neurodegenerative Diseases

Retrieved on: 
Tuesday, April 18, 2023
Science, Neurology, Research, General Health, Health, Health Technology, Clinical Trials, Other Health, DSM-IV codes, Clinical trial, Disorder, Tacrine, Beth Israel Deaconess Hospital-Plymouth, Acquisition, MD, Patient, Division, Beth Israel, Diagnosis, Hospital, Principal, Memory, Pharmaceutical industry, Medical device

Headlands Research , a leading multinational network of clinical trial sites, today announced the acquisition of an established clinical research site, now known as Headlands Research Eastern Massachusetts.

Key Points: 
  • Headlands Research , a leading multinational network of clinical trial sites, today announced the acquisition of an established clinical research site, now known as Headlands Research Eastern Massachusetts.
  • “With its longstanding focus on memory and movement disorders, Headlands Research Eastern Massachusetts strengthens the breadth and depth of our existing neurology specialty research,” said Cathy Collins, CEO of Headlands Research.
  • Headlands Research also recently announced the launch of Headlands Research Detroit and has plans to continue expanding its network throughout 2023.
  • To learn more about Headlands Research and its extensive network of research sites, visit https://headlandsresearch.com , contact [email protected] , or follow the company on LinkedIn .

New Approach to Safe Patient Limits on Beacon Hill by MNA Nurses and Healthcare Professionals Joins Legislation to Tackle Longstanding & Untenable Staffing Conditions Exacerbated by the COVID-19 Pandemic

Retrieved on: 
Thursday, January 19, 2023
Umbrella, Weeping, Radio, Hospital, Cape Cod Times, Falls, Cape Cod, Legislature, Good Samaritan Hospital, Length of stay, Advertising, Probability, Aggression, Attention, BMJ Quality & Safety, Health, Health services research, Massachusetts health care reform, Centers for Medicare & Medicaid Services, Hope, Patient, Impulsivity, United States Army Nurse Corps, Observational study, Research, Workforce, Multimedia, MNA, Workforce development, Falmouth Hospital, Question 1, Workplace, Commonwealth, Legislation, Center for Medicare and Medicaid Innovation, Beth Israel, Cooley Dickinson Hospital, WBUR, COVID-19, Confusion, MHA, American Hospital Association, Risk, Documentation, Medicare, St. Vincent Hospital, Patient safety, Pain, Medicine, Health insurance, Nursing, Safety

BOSTON, Jan. 19, 2023 /PRNewswire/ -- The more than 25,000 nurses and healthcare professionals of the Massachusetts Nurses Association have joined with allies in the Massachusetts House and Senate to file new legislation that would enact safe patient limits for all hospital units through a process led by the Department of Public Health.

Key Points: 
  • "…fewer nurses likely increase the probability that patients do not feel cared for with an adequate amount of time or attention.
  • That legislation would have funded independent research studies on nurse staffing, the supply of nurses, and measures of care quality.
  • In addition to the new safe patient limits law, the MNA is filing with its legislative sponsors nearly 20 other bills.
  • Founded in 1903, the Massachusetts Nurses Association is the largest union of registered nurses in the Commonwealth of Massachusetts.

IHI AWARDS $16.5 MILLION IN GRANTS FROM BLUE CROSS BLUE SHIELD OF MASSACHUSETTS TO IMPROVE HEALTH EQUITY IN MASS.

Retrieved on: 
Tuesday, September 27, 2022
Women's Equity Action League, Institute, YouTube, Health, Canadian Foundation for Healthcare Improvement, Time, Safety, Southcoast Health System, Movement, Twitter, Boston Medical Center, Hospital, Atrius Health, Organization, LinkedIn, Boston Children's Hospital, Hypertension, Bias, Beth Israel, Health equity, Optimism, CEO, Data collection, Solution, Blue Cross Blue Shield Association, Leadership, Death, Awareness, Mass General Brigham, IHI, AQC, Pharmaceutical industry, Health insurance, BCBSMA, Facebook

BOSTON, Sept. 27, 2022 /PRNewswire/ -- The Institute for Healthcare Improvement (IHI) has awarded $16.5 million in Blue Cross Blue Shield of Massachusetts (BCBSMA)-funded grants to 12 health systems across Massachusetts. The grants will fund projects to improve equity of care and race, ethnicity, and language data collection practices.

Key Points: 
  • The following organizations were awarded grants: Atrius Health, Boston Medical Center, Baycare Health Partners, Boston Children's Hospital, Beth Israel Lahey Health, Mass General Brigham, Reliant Medical Group, SoNE Health, South Shore Health, Southcoast Health, Steward, and Tufts Medicine Integrated Health.
  • "This is part of a multi-year commitment we've made to address health inequities," said Andrew Dreyfus, President and CEO of Blue Cross Blue Shield of Massachusetts.
  • "Blue Cross Blue Shield of Massachusetts is committed to collaborating with clinicians to support health equity efforts," said Dr. Mark Friedberg, the not-for-profit health plan's senior vice president, performance measurement & improvement.
  • Blue Cross Blue Shield of Massachusetts ( http://www.bluecrossma.org ) is a community-focused, tax-paying, not-for-profit health plan headquartered inBoston.

Clinical Trial Finds that Virtual Reality Therapy May Serve as Effective Adjunct To Anesthesia For Surgical Procedures

Retrieved on: 
Wednesday, September 21, 2022
PLOS, Software, Anesthetic, Efficiency, BIRD Foundation, Beth Israel Deaconess Medical Center, FDA, MD, Anesthesia, Health, Nerve, Relaxation, Synthetic control method, Environment, Beth Israel, Hand, Patient satisfaction, Patient, Clinical trial, CEO, Technology, CE, Pain, Anxiety, Patient safety, Bariatric surgery, XR, Rancho Los Amigos National Rehabilitation Center, Extended reality, Pain management, Virtual reality, Rehabilitation, Hospital, VR, Dentistry, Metaverse

BOSTON, Sept. 21, 2022 /PRNewswire/ -- The results of a clinical trial using software from XRHealth, developer and operator of virtual treatment rooms in the metaverse, published in PLOS ONE demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures. The trials were conducted with XRHealth's immersive virtual reality software.

Key Points: 
  • New Study Published in PLOS ONE Highlights Clinical Trial Findings; XRHealth Virtual Reality Therapy Aided Intraoperative Control of Pain and Anxiety without Intravenous Anesthetics
    BOSTON, Sept. 21, 2022 /PRNewswire/ --The results of a clinical trial using software from XRHealth , developer and operator of virtual treatment rooms in the metaverse, published in PLOS ONE demonstrated that virtual reality therapy may serve as an effective adjunct to anesthesia for surgical procedures.
  • Patients were randomized to intraoperative immersive virtual reality with intravenous anesthesia only given as needed, or to usual care as directed by the anesthesiologist.
  • The VR therapy software provided an immersive, engaging environment that guided patients through relaxation and pain reduction techniques while undergoing the surgery.
  • The company operates state-of-the-art therapeutic care Virtual Clinics, utilizing proprietary FDA and CE registered medical Extended Reality (XR) technology (virtual and augmented reality).

Dr. Scott D. James Becomes Leading Physician of The Vascular Care Group, Plymouth

Retrieved on: 
Tuesday, July 19, 2022
Professional Services, Health, Small Business, Hospitals, Surgery, Other Health, General Health, Beth Israel Deaconess Hospital-Plymouth, Stenosis, DO, Patient, Hospital, RPVI, Medicare Physician Group Practice (PGP) Demonstration, Vascular disease, Hope, Travel, Dialysis, Health, Diagnosis, Jordan Hospital, Lead, Beth Israel, Dentistry, Medicine

The Vascular Care Group (TVCG), announced today the opening of a new, state-of-the-art vascular center, located in Plymouth, Mass.

Key Points: 
  • The Vascular Care Group (TVCG), announced today the opening of a new, state-of-the-art vascular center, located in Plymouth, Mass.
  • The Plymouth vascular care center will be TVCGs tenth location in Massachusetts, reinforcing the teams commitment to the prevention, diagnosis and treatment of vascular disease in Massachusetts communities.
  • Vascular care centers, like this new Plymouth facility, put the patient at the center of the care model, said Dr. James.
  • Each care center has united some of the areas leading vascular specialists with a focus on superior patient care.

In Wake of Colleyville Attack, The Jewish Federation of Greater Washington Urges Local Community to Take Action

Retrieved on: 
Monday, January 31, 2022
Jewish Federation of San Diego County, Self-assessment, Social Security Protection Act of 2011, Security, Beth Israel, Community, Attack, FEMA, Safety, CEO, DHS, Organization, Federation, Region, National Security Advisor (Canada), Commune, Community Security Trust, Congress, SWAT, Partnership, Israeli Students Combating Antisemitism, National Directorate of Security, JCRC, Physical, Congregation Beth Israel (West Hartford, Connecticut), National Security Committee (Australia), Community Security Initiative, Clergy, SCN, National Capital Area Council, Violence, Common, Glass, National Federation of Community Broadcasters, Element, Jewish Community Relations Council of Minnesota and the Dakotas, Management, Medical device, Medicine, Washington metropolitan area, Jews

WASHINGTON, Jan. 31, 2022 /PRNewswire-PRWeb/ --In the aftermath of the antisemitic attack at Congregation Beth Israel in Colleyville, Texas, The Jewish Federation of Greater Washington hosted an important webinar on Friday on the security of the Jewish community in Greater Washington.

Key Points: 
  • WASHINGTON, Jan. 31, 2022 /PRNewswire-PRWeb/ --In the aftermath of the antisemitic attack at Congregation Beth Israel in Colleyville, Texas, The Jewish Federation of Greater Washington hosted an important webinar on Friday on the security of the Jewish community in Greater Washington.
  • "Through our close partnerships with the Jewish Community Relations Council (JCRC) and SCN, Federation remains committed to providing services and helping organizations access funding to strengthen Jewish Greater Washington's safety, security, and preparedness," said Federation CEO Gil Preuss.
  • The Jewish Federation also convened the region's first ever Communal Security Committee to engage all parts of the Greater Washington Jewish community on security concerns, needs, and best practices.
  • The Jewish Federation of Greater Washington envisions an open, connected, and vibrant Jewish community that cares for each other, fosters Jewish learning and journeys, embraces Jewish peoplehood and Israel, and acts as a force for good in the world.